跳至主要内容
临床试验/NCT02458599
NCT02458599已完成不适用

A Study to Evaluate the Effects of Protein Supplementation in Attenuating the Decline in Performance Following Strenuous Concurrent Exercise

GlaxoSmithKline2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
2
主要终点
Isometric Maximal Voluntary Contraction (MVC) Assessment

研究概览

简要总结

This study is designed to investigate whether protein supplementation can improve recovery of muscle function following a strenuous combination of both endurance and resistance exercise. It will specifically investigate the effect of protein supplementation on the recovery of strength, power and endurance exercise performance, along with measures of damage and inflammation of the muscle.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary informed consent form and has received signed and dated copy of the informed consent form
  • Male participants; age between 18 to 35 years, inclusive
  • Well trained endurance cyclist (competing at a minimum of Category 3 road-racing/estimated 10 mile TT of <23 minutes), with a training history >1 year
  • Good general and mental health

排除标准

  • Currently taking any nutritional supplements, polyphenols or beta-blockers, Non-steroidal anti-inflammatory drugs (NSAIDs), recreational drugs
  • Known or suspected intolerance or hypersensitivity to the study material or any of their stated ingredients
  • Allergy to milk or wheat products
  • Heart or any other medical condition that may contra-indicate participants from taking part in high intensity or exhaustive physical activity
  • Previous participation in this study; another clinical study or receipt of an investigational drug within 30 days of the screening visit; participation in another study involving a protocol to elicit Exercise-Induced Muscle Damage (EIMD) within 6 months of the screening visit

结局指标

主要结局

Isometric Maximal Voluntary Contraction (MVC) Assessment

时间窗: 96 hours (h)

Maximum voluntary isometric contraction (MVIC) will be assessed at the knee during a leg extension movement using an isokinetic dynamometer. MVIC will be used to assess strength. Participants will perform the exercise using the dominant leg at a knee joint angle of 70º three times, with a contraction of 3 seconds (s) on each occasion (each contraction separated by 60 s rest). The peak force (measured in Newton) generated across the three repetitions will be recorded.

Counter Movement Jump (CMJ) Assessment

时间窗: 96 h

Power will be assessed using counter-movement jump. Participants will place their hands on their hips, descend rapidly to \~90º knee joint angle, and then jump as high as possible using a counter-movement. Three jumps will be performed (each jump separated by 60 s rest) and the peak vertical jump height (measured in centimeters) will be recorded.

16.1 Kilometer (km) Cycling Time Trial (TT) Assessment

时间窗: 96 h

The 16.1 km cycling TT assessment will be performed on a cycling ergometer. Participants will be required to complete a distance of 16.1 km in as short a time as possible, while being blinded to time elapsed.

次要结局

  • Serum Creatine Kinase Analysis(96 h)
  • Serum C-Reactive Protein Analysis(96 h)
  • Perceived Muscle Soreness Assessment(96 h)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验